Health care companies by P/S ratio
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Centene has the lowest figure of the 154 health care companies ranked by P/S ratio, at 0.2, followed by Cencora (0.2) and Molina Healthcare (0.2). Figures as of 19 Nov 2026, 12:43 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 154
- Lowest
- Centene0.2
- Median
- 4.3
- Combined market value
- PLN 36.54T
- Countries
- 14
- Not ranked
- 16no P/S ratio on file
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | P/S ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 101 | Medpace HoldingsMEDP · Health Care | 7.2 | PLN 72.7B | PLN 2,598.80 | 0.95% down | 10% up | ||
| 102 | ExelixisEXEL · Health Care | 7.2 | PLN 66.9B | PLN 274.36 | 0.31% down | 63% up | ||
| 103 | Agilent TechnologiesA · Health Care | 7.2 | PLN 200.9B | PLN 712.42 | 2.97% up | 22% up | ||
| 104 | IlluminaILMN · Health Care | 7.3 | PLN 127.6B | PLN 843.72 | 3.65% up | 76% up | ||
| 105 | Arrowhead PharmaceuticalsARWR · Health Care | 7.3 | PLN 24.5B | PLN 173.19 | 0.28% up | 13% up | ||
| 106 | United TherapeuticsUTHR · Health Care | 7.7 | PLN 98.8B | PLN 2,319.46 | 1.16% down | 22% up | ||
| 107 | Halozyme TherapeuticsHALO · Health Care | 7.8 | PLN 43.9B | PLN 384.88 | 0.18% down | 39% up | ||
| 108 | AbbVieABBV · Health Care | 8.3 | PLN 2.03T | PLN 1,149.05 | 2.33% down | 25% up | ||
| 109 | GenmabGMAB · Health Care | 8.4 | PLN 126.3B | PLN 204.77 | 1.91% down | 70% up | ||
| 110 | Mettler-Toledo InternationalMTD · Health Care | 8.6 | PLN 138.8B | PLN 6,979.44 | 1.42% up | 24% up | ||
| 111 | BeOne MedicinesONC · Health Care | 8.6 | PLN 185.2B | PLN 1,621.46 | 2.34% down | 16% up | ||
| 112 | PenumbraPEN · Health Care | 9.0 | PLN 50.8B | PLN 1,288.01 | 0.47% up | 15% up | ||
| 113 | West Pharmaceutical ServicesWST · Health Care | 9.2 | PLN 113.1B | PLN 1,623.15 | 2.44% down | 57% up | ||
| 114 | Bio-TechneTECH · Health Care | 9.4 | PLN 45.9B | PLN 292.27 | 0.17% up | 24% up | ||
| 115 | Madrigal PharmaceuticalsMDGL · Health Care | 9.6 | PLN 37.2B | PLN 1,599.29 | 5.67% down | 27% down | ||
| 116 | Corcept TherapeuticsCORT · Health Care | 9.7 | PLN 29.8B | PLN 272.35 | 3.25% down | 10% down | ||
| 117 | Travere TherapeuticsTVTX · Health Care | 9.8 | PLN 19.4B | PLN 201.84 | 1.68% down | 45% up | ||
| 118 | Edwards LifesciencesEW · Health Care | 10.0 | PLN 243.1B | PLN 422.76 | 0.19% down | 25% up | ||
| 119 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 11.0 | PLN 30B | PLN 381.86 | 0.06% down | 129% up | ||
| 120 | Axsome TherapeuticsAXSM · Health Care | 11.0 | PLN 28.3B | PLN 538.35 | 1.43% down | 6% down | ||
| 121 | Vertex PharmaceuticalsVRTX · Health Care | 11.3 | PLN 546.4B | PLN 2,155.19 | 0.42% up | 27% up | ||
| 122 | Mirum PharmaceuticalsMIRM · Health Care | 11.6 | PLN 24.3B | PLN 371.58 | 0.59% up | 34% up | ||
| 123 | 10x GenomicsTXG · Health Care | 11.7 | PLN 30.2B | PLN 229.28 | 1.37% up | 247% up | ||
| 124 | IDEXX LaboratoriesIDXX · Health Care | 12.8 | PLN 221.1B | PLN 2,806.10 | 1.19% up | 1% up | ||
| 125 | argenxARGX · Health Care | 14.3 | PLN 237.8B | PLN 3,781.47 | 0.66% down | 2% up | ||
| 126 | BillionToOneBLLN · Health Care | 14.3 | PLN 17.6B | PLN 367.76 | 6.11% down | 4% down | ||
| 127 | Intuitive SurgicalISRG · Health Care | 14.5 | PLN 586.2B | PLN 1,691.17 | 2.23% down | 24% down | ||
| 128 | RepligenRGEN · Health Care | 15.0 | PLN 44.3B | PLN 693.70 | 6.47% up | 12% up | ||
| 129 | TG TherapeuticsTGTX · Health Care | 16.2 | PLN 40.2B | PLN 265.64 | 5.44% up | 117% up | ||
| 130 | Royalty PharmaRPRX · Health Care | 16.6 | PLN 158.6B | PLN 275.88 | 0.01% down | 79% up | ||
| 131 | Adaptive BiotechnologiesADPT · Health Care | 16.6 | PLN 18.5B | PLN 114.34 | 0.11% down | 74% up | ||
| 132 | NateraNTRA · Health Care | 18.2 | PLN 168.6B | PLN 1,163.07 | 0.71% up | 28% up | ||
| 133 | Eli LillyLLY · Health Care | 18.9 | PLN 4.95T | PLN 5,555.20 | 2.32% down | 33% up | ||
| 134 | Guardant HealthGH · Health Care | 20.0 | PLN 78.9B | PLN 583.10 | 1.30% up | 45% up | ||
| 135 | Twist BioscienceTWST · Health Care | 21.1 | PLN 31.9B | PLN 467.44 | 3.88% up | 346% up | ||
| 136 | Ascendis PharmaASND · Health Care | 22.2 | PLN 71.2B | PLN 1,086.05 | 0.32% down | 29% up | ||
| 137 | Ligand PharmaceuticalsLGND · Health Care | 22.3 | PLN 24B | PLN 1,200.07 | 1.67% up | 50% up | ||
| 138 | HeartflowHTFL · Health Care | 22.9 | PLN 16.2B | PLN 184.36 | 2.51% down | 66% up | ||
| 139 | Krystal BiotechKRYS · Health Care | 24.0 | PLN 37.5B | PLN 1,266.88 | 5.62% up | 54% up | ||
| 140 | GlaukosGKOS · Health Care | 27.2 | PLN 55.4B | PLN 936.40 | 4.18% down | 145% up | ||
| 141 | WatersWAT · Health Care | 28.9 | PLN 368B | PLN 1,872.56 | 3.63% up | 23% up | ||
| 142 | BridgeBio PharmaBBIO · Health Care | 30.3 | PLN 61.1B | PLN 313.41 | 1.58% up | 21% up | ||
| 143 | GRAILGRAL · Health Care | 31.2 | PLN 18.4B | PLN 410.19 | 3.57% down | 19% up | ||
| 144 | ModernaMRNA · Health Care | 41.0 | PLN 319.9B | PLN 790.60 | 4.84% down | 780% up | ||
| 145 | InsmedINSM · Health Care | 43.3 | PLN 105.6B | PLN 481.30 | 1.69% down | 40% down | ||
| 146 | Rhythm PharmaceuticalsRYTM · Health Care | 43.5 | PLN 33.2B | PLN 478.24 | 2.08% up | 18% up | ||
| 147 | ImmunityBioIBRX · Health Care | 62.9 | PLN 28.6B | PLN 26.92 | 7.03% up | 232% up | ||
| 148 | CytokineticsCYTK · Health Care | 81.2 | PLN 28.7B | PLN 206.18 | 0.64% down | 19% down | ||
| 149 | Protagonist TherapeuticsPTGX · Health Care | 180 | PLN 33.3B | PLN 510.87 | 2.00% up | 51% up | ||
| 150 | Kymera TherapeuticsKYMR · Health Care | 264 | PLN 41.5B | PLN 486.64 | 0.32% down | 87% up | ||
| 151 | CRISPR TherapeuticsCRSP · Health Care | 1111 | PLN 15.7B | PLN 161.46 | 0.10% up | 18% down | ||
| 152 | CG OncologyCGON · Health Care | 1769 | PLN 28.7B | PLN 321.40 | 1.34% up | 97% up | ||
| 153 | Dianthus TherapeuticsDNTH · Health Care | 2323 | PLN 19B | PLN 337.39 | 3.45% down | 108% up | ||
| 154 | Roivant SciencesROIV · Health Care | 3397 | PLN 112.7B | PLN 155.60 | 0.05% up | 91% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0175 PLN). 16 companies have no P/S ratio on file and are not ranked here.
Questions and answers
Which health care companies have the lowest P/S ratio?
Centene (0.2), Cencora (0.2) and Molina Healthcare (0.2) have the lowest P/S ratio of the 154 health care companies ranked here as of 19 Nov 2026, 12:43 UTC.
How many health care companies are in this ranking?
154 are ranked by P/S ratio. 16 more have no P/S ratio on file and are left out rather than ranked at zero.
What are these health care companies worth together?
The 154 health care companies ranked by P/S ratio have a combined market value of PLN 36.54T as of 19 Nov 2026, 12:43 UTC.
What does ranking by P/S ratio measure?
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies by P/S ratio”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=ps-ratio
Underlying data: Yahoo Finance; SEC EDGAR.